UK VC firm launch­es strate­gic re­view, pon­ders shut­down

Ar­ix Bio­science is con­duct­ing a strate­gic re­view that could in­clude wind­ing down the UK-based ven­ture cap­i­tal firm.

Ar­ix said it is eval­u­at­ing its in­vest­ment strate­gies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER